However, high levels of TROAP have been reported in several cancer types, including serous ovarian carcinoma, suggesting its utility as a marker for cancer progression and prognosis (Partheen et al., 2008; Godoy et al., 2013; Hu et al., 2019; Liu H. et al., 2022; Li et al., 2022). The gene discussed is TROAP; the disease is cancer.